ACUITY MEDICAL MACULAR DEGENERATION DEVICE SHOWS POSITIVE RESULTS IN FDA TRIAL
Acuity Medical has successfully completed a proof of concept FDA-compliant trial
of its TheraMac device for the treatment of dry age-related macular degeneration
(AMD). AMD is the leading cause of legal blindness effecting more than 50 million
people worldwide. The trial showed that in two weeks 26 percent of the eyes
treated had improved vision by 10 letters or more, the equivalent of two lines
on the eye chart. There were zero serious adverse events.